J-pharma Co., Ltd.
Clinical trials sponsored by J-pharma Co., Ltd., explained in plain language.
-
New hope for bile duct cancer: experimental drug enters final testing phase
Disease control Recruiting nowThis study tests a new drug called nanvuranlat in people with advanced biliary tract cancer (bile duct cancer) that has already been treated. About 480 adults will receive either nanvuranlat or standard treatments (chemotherapy or supportive care). The goal is to see if nanvuranl…
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New drug JPH034 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, JPH034, in 40 healthy adults aged 18 to 50. Participants receive either the drug or a placebo to check for side effects and measure how the drug moves through the body. The goal is to gather safety information, not to treat any diseas…
Phase: PHASE1 • Sponsor: J-Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC